Abbott Issues Safety Notification for FreeStyle Libre® Family of Readers in the U.S.
Abbott initiated a voluntary medical device correction in February to emphasize instructions for its FreeStyle Libre®, FreeStyle Libre® 14 day and FreeStyle Libre® 2 Readers in the United States due to a limited number of reports worldwide (0.0017%) from users over several years that their reader’s
Source: fda.gov